2024
DNA methylation in long COVID
Xiao Y, Vermund S. DNA methylation in long COVID. Frontiers In Virology 2024, 4: 1371683. DOI: 10.3389/fviro.2024.1371683.Peer-Reviewed Original ResearchDNA methylationSevere acute respiratory syndromeAcute coronavirus disease 2019Middle East respiratory syndromeLong-term sequelaeDNA methylation phenomenonLong COVIDPredictive of outcomeCombination of clinical signsAcute COVID-19DNA methylation markersVirus-host interactionsLong lasting persistenceSevere acute respiratory syndrome coronavirus 2Acute respiratory syndrome coronavirus 2Respiratory syndrome coronavirus 2Respiratory syndromeChronic symptomsEpigenetic phenomenaSyndrome coronavirus 2Evolving syndromeCoronavirus disease 2019Long COVID patientsSyndromeAcute respiratory syndrome
2023
Differences in syncytia formation by SARS-CoV-2 variants modify host chromatin accessibility and cellular senescence via TP53
Lee J, Menasche B, Mavrikaki M, Uyemura M, Hong S, Kozlova N, Wei J, Alfajaro M, Filler R, Müller A, Saxena T, Posey R, Cheung P, Muranen T, Heng Y, Paulo J, Wilen C, Slack F. Differences in syncytia formation by SARS-CoV-2 variants modify host chromatin accessibility and cellular senescence via TP53. Cell Reports 2023, 42: 113478. PMID: 37991919, PMCID: PMC10785701, DOI: 10.1016/j.celrep.2023.113478.Peer-Reviewed Original ResearchConceptsChromatin accessibilityProteomic compositionCellular senescenceTP53 stabilizationSARS-CoV-2 spikeCell-cell fusionPathogenic coronavirusesSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variantsSenescence-associated inflammationSARS-CoV-2 infectionMiddle East respiratory syndromeAccessibility stateInflammatory cytokine releaseSevere respiratory infectionsSARS-CoV-2 variantsSignificant public health threatCoronavirus disease 2019SARS-CoV-2Public health threatBreakthrough infectionsRespiratory infectionsCytokine releaseSenescenceDisease 2019Respiratory syndrome
2020
A Clinic Blueprint for Post-Coronavirus Disease 2019 RECOVERY Learning From the Past, Looking to the Future
Lutchmansingh DD, Knauert MP, Antin-Ozerkis DE, Chupp G, Cohn L, Dela Cruz CS, Ferrante LE, Herzog EL, Koff J, Rochester CL, Ryu C, Singh I, Tickoo M, Winks V, Gulati M, Possick JD. A Clinic Blueprint for Post-Coronavirus Disease 2019 RECOVERY Learning From the Past, Looking to the Future. CHEST Journal 2020, 159: 949-958. PMID: 33159907, PMCID: PMC7641526, DOI: 10.1016/j.chest.2020.10.067.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsAcute diseaseRespiratory syndromeSevere acute respiratory syndrome coronavirus 2Acute respiratory syndrome coronavirus 2Post-intensive care syndromePotential long-term complicationsCOVID-19Respiratory syndrome coronavirus 2Middle East respiratory syndromeSevere acute respiratory syndromeCoronavirus disease 2019 (COVID-19) casesPersistent respiratory symptomsLong-term complicationsCOVID-19 survivorsSyndrome coronavirus 2Acute respiratory syndromeCOVID-19 outcomesChronic complicationsPersistent symptomsRespiratory symptomsCoronavirus 2Lung diseaseNonhospitalized individualsClinical programsComplicationsNeuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019
Zubair AS, McAlpine LS, Gardin T, Farhadian S, Kuruvilla DE, Spudich S. Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019. JAMA Neurology 2020, 77: 1018-1027. PMID: 32469387, PMCID: PMC7484225, DOI: 10.1001/jamaneurol.2020.2065.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsCentral nervous systemCoronavirus disease 2019Nervous systemDisease 2019Respiratory syndromeCOVID-19Severe acute respiratory syndrome coronavirus 2Acute respiratory syndrome coronavirus 2Long-term neurologic sequelaeRespiratory syndrome coronavirus 2Middle East respiratory syndromeSevere acute respiratory syndromeClinical neurological complicationsFurther neuropathological studiesBest treatment algorithmImproved clinical outcomesBlood-brain barrierImpairment of consciousnessSyndrome coronavirus 2Peripheral nervous systemAcute respiratory syndromeHuman coronavirus disease 2019Common neurologic complaintsSARS-CoV-2Neurologic sequelaePrior and novel coronaviruses, Coronavirus Disease 2019 (COVID-19), and human reproduction: what is known?
Segars J, Katler Q, McQueen DB, Kotlyar A, Glenn T, Knight Z, Feinberg EC, Taylor HS, Toner JP, Kawwass JF, Force A. Prior and novel coronaviruses, Coronavirus Disease 2019 (COVID-19), and human reproduction: what is known? Fertility And Sterility 2020, 113: 1140-1149. PMID: 32482250, PMCID: PMC7161522, DOI: 10.1016/j.fertnstert.2020.04.025.Peer-Reviewed Original ResearchMeSH KeywordsBetacoronavirusCoronavirus InfectionsCOVID-19FemaleFertilityHost-Pathogen InteractionsHumansInfertility, FemaleInfertility, MaleMaleOrchitisPandemicsPneumonia, ViralPregnancyPregnancy Complications, InfectiousPregnancy OutcomeReproductionRisk AssessmentRisk FactorsSARS-CoV-2Sperm CountSperm MotilityConceptsCoronavirus disease 2019 (COVID-19) infectionDisease 2019 infectionMiddle East respiratory syndromeSevere acute respiratory syndrome coronavirus 1Maternal case fatality rateSARS-CoV-2 infectionCase fatality rateGerm cell destructionCOVID-19 infectionCoronavirus disease 2019SARS coronavirus 2Human reproductionNeonatal complicationsNeonatal transmissionPreterm deliveryPregnancy outcomesAsymptomatic womenPregnant womenHuman ovarySevere orchitisDisease 2019Enzyme 2Respiratory syndromeMAIN OUTCOMEReproductive outcomesDetection of novel coronaviruses in bats in Myanmar
Valitutto MT, Aung O, Tun KYN, Vodzak ME, Zimmerman D, Yu JH, Win YT, Maw MT, Thein WZ, Win HH, Dhanota J, Ontiveros V, Smith B, Tremeau-Brevard A, Goldstein T, Johnson CK, Murray S, Mazet J. Detection of novel coronaviruses in bats in Myanmar. PLOS ONE 2020, 15: e0230802. PMID: 32271768, PMCID: PMC7144984, DOI: 10.1371/journal.pone.0230802.Peer-Reviewed Original ResearchConceptsMiddle East respiratory syndromeSevere acute respiratory syndromeRespiratory syndromeAcute respiratory illnessAcute respiratory syndromeCoronavirus disease 2019Family of coronavirusesRespiratory illnessPolymerase chain reactionNovel betacoronavirusDisease 2019Vigilant surveillanceOral swabsConventional polymerase chain reactionViral detectionNovel coronavirusCausative agentChain reactionKnown coronavirusesSyndromeSurveillance activitiesCoronavirusNatural hostSurveillanceClose contact
2018
Clinical outcomes of current medical approaches for Middle East respiratory syndrome: A systematic review and meta‐analysis
Morra M, Van Thanh L, Kamel M, Ghazy A, Altibi A, Dat L, Thy T, Vuong N, Mostafa M, Ahmed S, Elabd S, Fathima S, Le Huy Vu T, Omrani A, Memish Z, Hirayama K, Huy N. Clinical outcomes of current medical approaches for Middle East respiratory syndrome: A systematic review and meta‐analysis. Reviews In Medical Virology 2018, 28: e1977. PMID: 29664167, PMCID: PMC7169085, DOI: 10.1002/rmv.1977.Peer-Reviewed Original ResearchConceptsChronic renal diseaseMiddle East respiratory syndromeRenal diseaseSupportive treatmentEfficacy of antiviral drugsAssociated with worse outcomesAntiviral drugsIFN-treated groupLarge-scale prospective randomized studiesProspective randomized studyMonitoring of adverse eventsRisk of mortalitySystematic literature searchOlder age groupsMiddle east respiratory syndrome patientsIFN groupCase fatality rateRandomized studyClinical outcomesAdverse eventsPreexisting comorbiditiesIFN treatmentWorse outcomesSystematic reviewTherapeutic efficacy
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply